Transversalis Fascia Plane Block Versus Intrathecal Dexmedetomidine in Patients Undergoing Cesarean Section
Analgesic Efficacy of Transversalis Fascia Plane Block Versus Intrathecal Dexmedetomidine in Patients Undergoing Cesarean Section: A Randomized Controlled Trial
Tanta University
50 participants
Sep 13, 2025
INTERVENTIONAL
Conditions
Summary
This study aims to compare the analgesic efficacy of the transversalis fascia plane (TFP) block and intrathecal dexmedetomidine in patients undergoing cesarean section (CS).
Eligibility
Inclusion Criteria3
- Age from 18 to 40 years.
- American Society of Anesthesiology (ASA) physical status II.
- Women undergoing cesarean section under spinal anesthesia.
Exclusion Criteria11
- Contraindication to spinal anesthesia.
- Women with body mass index \>40 kg/m2.
- Pregnancy-induced hypertension
- Local infection at the site of injection.
- Known cardiovascular disease
- Coagulation abnormality.
- History of chronic pain.
- Abuse of drugs or alcohol.
- History of allergies to any study medications.
- Seizure disorders.
- Any pregnancy complications requiring conversion to general anesthesia.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients will receive spinal anesthesia (using 2.5 mL of hyperbaric bupivacaine 0.5%) with bilateral transversalis fascia plane (TFP) block (using 20 mL of bupivacaine 0.25%) at the end of surgery.
Patients will receive spinal anesthesia (using 2.5 mL of hyperbaric bupivacaine 0.5%) + (5 µg intrathecal dexmedetomidine diluted in 0.5ml saline) with a sham block at the end of surgery.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07170267